Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review.
Irene E van der Horst-BruinsmaPhilip C RobinsonEnnio G FavalliFrank D VerbraakMindy KimThomas KumkeLars BauerBengt HoepkenAtul DeodharPublished in: Rheumatology and therapy (2022)
CZP was effective in reducing AAU incidence in clinical trials with patients with axSpA. The targeted literature review, however, highlighted that there remains a paucity of data beyond these trials. Data from comparative studies would further enhance the body of evidence on the effects of CZP in patients with axSpA who develop AAU.
Keyphrases
- clinical trial
- electronic health record
- ankylosing spondylitis
- big data
- liver failure
- risk factors
- respiratory failure
- cancer therapy
- juvenile idiopathic arthritis
- randomized controlled trial
- drug induced
- rheumatoid arthritis
- data analysis
- aortic dissection
- drug delivery
- systemic lupus erythematosus
- phase ii
- hepatitis b virus
- open label
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome